However, the expression levels of IL‐12, CD47, and SLAMF7 were higher in tumors than in adjacent non‐tumorous tissues (Figure 1E), as determined by analyzing their mRNA expression levels in glioma patients using TCGA and GTEx datasets. This evidence concerns the gene CD47 and central nervous system cancer.